The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Digital Edition Archives Authors Reviewers

Page 2

More JCP Articles

JCP
Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality
Clinical and Practical Psychopharmacology

Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality

August 31, 2026

Evidence on the association of ECT with lower risk of short- and long-term all-cause mortality, nonsuicide mortality, and suicide mortality is reviewed.
JCP
Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment
Original Research

Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.
,
JCP
The Prescriber’s Guide to Oral Ketamine for Depression
Clinical and Practical Psychopharmacology

The Prescriber’s Guide to Oral Ketamine for Depression

August 26, 2026

Explains clinical contexts in which oral ketamine can be used and presents a detailed protocol for the use of this intervention.
JCP
From Screening to Treatment: Rethinking Suicide Risk with Elizabeth Ballard, PhD
Podcast

From Screening to Treatment: Rethinking Suicide Risk with Elizabeth Ballard, PhD

August 25, 2026

Dr. Elizabeth Ballard discusses suicide risk screening tools, ketamine’s rapid antisuicidal effects, sleep biomarkers, and ethics of suicide research.
,
JCP
Life’s Essential 8 Cardiovascular Health and Suicide Mortality
Original Research

Life’s Essential 8 Cardiovascular Health and Suicide Mortality

August 19, 2026

Poor cardiovascular health status, as reflected by a low Life’s Essential 8 score, was associated with suicide mortality.
,
JCP
Persistent Gaps in Diversity of US Antidepressant Trials
Original Research

Persistent Gaps in Diversity of US Antidepressant Trials

August 12, 2026

Reporting gaps and multiple underrepresented groups persist in US antidepressant trials, limiting generalizability.
, , , et al
JCP
Time Trends in Maternal ADHD and Medication Use in Pregnancy
Original Research

Time Trends in Maternal ADHD and Medication Use in Pregnancy

August 12, 2026

The 4-fold increase in maternal ADHD in pregnancy over a 20-year period and 2-fold increase in use of stimulants before and during pregnancy underline the need for guidance on…
, , , et al
JCP
Feeding the Mind: Metabolism in Psychiatry with David T. Liebers, MD, MPhil, MPP
Podcast

Feeding the Mind: Metabolism in Psychiatry with David T. Liebers, MD, MPhil, MPP

August 11, 2026

Dr. David Liebers on metabolic psychiatry: ketogenic diets, SGLT2 inhibitors, and metformin for bipolar disorder, schizophrenia, and mitochondrial dysfunction.
,
JCP
Relative Infant Dose for Maternal Use of Drugs During Breastfeeding
Clinical and Practical Psychopharmacology

Relative Infant Dose for Maternal Use of Drugs During Breastfeeding

August 10, 2026

Relative infant dose is explained using a worked example, and clinically important issues in its derivation, interpretation, and application are discussed.
JCP
Association of Lithium Use With Suicide and Self-Harm Among Chinese Adolescents and Adults With Bipolar Disorder
Original Research

Association of Lithium Use With Suicide and Self-Harm Among Chinese Adolescents and Adults With Bipolar Disorder

August 10, 2026

Lithium was associated with a 40% lower risk of suicidal ideation and reduced suicidal behaviors in patients with bipolar disorder
, , , et al
JCP
When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?
ASCP Corner

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

August 6, 2026

Focuses on descriptive symptom phenomenology and strategies to minimize discomfort during antidepressant cessation, with possible explanations for unusual, delayed, or protracted symptoms in patients for whom non-pharmacodynamic features may…
, , , et al
JCP
Pharmacokinetics of Viloxazine ER in Breast Milk
Original Research

Pharmacokinetics of Viloxazine ER in Breast Milk

August 5, 2026

This pharmacokinetic study demonstrates low drug presence in breast milk, with relative infant dose ~1%–2% of the maternal weight-based dose.
, , , et al

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe